-
STRATEGIC COMPARISON OF CENTER FOR PHARMACOECONOMICS AND INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW ECONOMIC EVALUATIONS
Mar 18, 2026, 21:38 PM -
A MULTI-INDICATION HEALTH TECHNOLOGY ASSESSMENT FRAMEWORK FOR ONCOLOGICAL DRUGS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM (SUS)
Mar 18, 2026, 21:38 PM -
COMPARATIVE EFFECTIVENESS OF PHARMACOLOGICAL TREATMENTS FOR STABLE CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE CHINESE POPULATION: A BAYESIAN NETWORK META ANALYSIS
Mar 18, 2026, 21:38 PM -
PREDICTORS OF GLP-1 RECEPTOR AGONIST USE AMONG U.S. ADULTS WITH COMORBID DEPRESSION AND TYPE 2 DIABETES MELLITUS
Mar 18, 2026, 21:38 PM -
THE IMPACT OF SIMPLIFIED DOSING TERMINOLOGY ON TREATMENT EXPOSURE AND BUSGET IMPACT ESTIMATES
Mar 18, 2026, 21:38 PM -
UNIT-CONSISTENT TRANSLATION OF TREATMENT EFFECTS INTO NUMBER NEEDED TO TREAT AND COST PER EVENT AVOIDED IN HEALTH ECONOMIC EVALUATIONS
Mar 18, 2026, 21:38 PM -
THE IMPACT OF PERIOPERATIVE IMMUNE CHECKPOINT INHIBITORS ON THE ECONOMIC BURDEN OF BLADDER CANCER IN CANADA
Mar 18, 2026, 21:38 PM -
DATA-DRIVEN BASELINE MATCHING: ENHANCING INDIRECT COMPARISONS WITH A MACHINE LEARNING-INFORMED FRAMEWORK FOR SELECTING HOMOGENEOUS TRIAL SETS
Mar 18, 2026, 21:38 PM -
PATIENT-REPORTED OUTCOMES IN UNITED STATES PROMOTIONAL COMMUNICATIONS FOR DRUGS AND BIOLOGICS: A REVIEW OF DRUG PROMOTION UNTITLED LETTERS FROM THE FDA
Mar 18, 2026, 21:38 PM -
COMPARATIVE EFFECTIVENESS ANALYSIS OF FOLFIRINOX AND GEMCITABINE PLUS NAB-PACLITAXEL IN METASTATIC PANCREATIC ADRENOCARCINOMA; USING MARGINAL STRUCTURAL MODEL
Mar 18, 2026, 21:38 PM -
THE ROLE OF SAFETY AND TOLERABILITY IN HTA VALUE ASSESSMENT: EVIDENCE REQUIREMENTS AND IMPACT ACROSS KEY EUROPEAN MARKETS
Mar 18, 2026, 21:38 PM -
THE MARKET FOR MONOCLONAL ANTIBODIES: TRENDS, CHALLENGES, AND OPPORTUNITIES
Mar 18, 2026, 21:38 PM -
ASSESSING QUALITY OF A LARGE LANGUAGE MODEL (LLM)-DERIVED PROSTATE CANCER (PC) REAL-WORLD DATASET: AN APPLICATION OF THE VALIDATION OF ACCURACY FOR LLM/ML-EXTRACTED INFORMATION AND DATA (VALID) FRAMEWORK
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS AND BUDGET IMPACT OF THE ETONOGESTREL SUBDERMAL IMPLANT INCORPORATING REAL-WORLD UTILIZATION DATA FROM A LARGE BRAZILIAN PRIVATE HEALTH INSURER
Mar 18, 2026, 21:38 PM -
INVESTIGATING THE CHARACTERISTICS ASSOCIATED WITH PRESCRIBED OPIOID USE IN U.S. ADULTS WITH LONG COVID
Mar 18, 2026, 21:38 PM -
REAL-WORLD EVIDENCE (RWE) ON BRUTON TYROSINE KINASE INHIBITORS (BTKIS) IN TREATMENT-NAIVE (TN) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) OR SMALL LYMPHOCYTIC LYMPHOMA (SLL): AN ARTIFICIAL INTELLIGENCE (AI)-ASSISTED LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
DEVELOPMENT OF AN ALCOHOL USE DISORDER IDENTIFICATION MODEL USING ELECTRONIC HEALTH RECORD-DERIVED FEATURES FOR CLINICAL IMPLEMENTATION
Mar 18, 2026, 21:38 PM -
ENHANCING REAL-WORLD DATA (RWD) QUALITY: IMPLEMENTATION OF REGULATORY DATA QUALITY FRAMEWORK WITHIN A LARGE US ONCOLOGY ELECTRONIC HEALTH RECORD (EHR)-DERIVED DATABASE
Mar 18, 2026, 21:38 PM -
IMPACT OF PULMONARY ARTERIAL HYPERTENSION ON HEART-LUNG TRANSPLANTATION OUTCOMES AND COSTS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
COST-OF-ILLNESS OF PNEUMONIA, BACTEREMIA OR MENINGITIS IN COLOMBIAN ADULTS: A RETROSPECTIVE DATABASE STUDY, 2015 TO 2022
Mar 18, 2026, 21:38 PM
